Acciones Shanghai Pharmaceuticals Holding Co., Ltd Other OTC
Acciones
SHPMY
US81943R1005
Farmacéuticos
Ventas 2024 * | 288 mil M 39,62 mil M 37,1 mil M | Ventas 2025 * | 317 mil M 43,68 mil M 40,89 mil M | Capitalización | 62,6 mil M 8614,69 M 8064,85 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 4967 M 684 M 640 M | Resultado Neto 2025 * | 5599 M 771 M 721 M | VE / Ventas 2024 * | 0,28 x |
Deuda neta 2024 * | 18,42 mil M 2534,47 M 2372,71 M | Deuda neta 2025 * | 19,41 mil M 2671,69 M 2501,17 M | VE / Ventas 2025 * | 0,26 x |
P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
12,4
x | Empleados | - |
Rendimiento 2024 * |
2,81 % | Rendimiento 2025 * |
3,18 % | Flotante | 38,5 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Yong Zhong Li
PSD | President | 54 | 27/06/19 |
Bo Shen
PSD | President | 51 | 05/06/13 |
Ye Lu
IRC | Investor Relations Contact | 35 | 01/01/16 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bo Shen
PSD | President | 51 | 05/06/13 |
Yong Zhong Li
PSD | President | 54 | 27/06/19 |
Manson Fok
BRD | Director/Board Member | 67 | 27/06/19 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,05 % | 78,4 mil M | |
+0,53 % | 25,12 mil M | |
+2,20 % | 8551,58 M | |
-28,87 % | 6907,15 M | |
+16,06 % | 5338,43 M | |
+1,58 % | 4165,13 M | |
-8,90 % | 3824,48 M | |
-7,62 % | 3368,3 M | |
+9,36 % | 3260,35 M |